Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vertex Pharma | Mexico | Healthcare | Biotechnology & Medical Research | MXN 2.44T | -247.5x | 2.48 | MXN 10,182 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moderna | Mexico | Healthcare | Biotechnology & Medical Research | MXN 289.20B | -6.4x | -0.23 | MXN 754 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CRISPR Therapeutics AG | Mexico | Healthcare | Biotechnology & Medical Research | MXN 82.06B | -16.3x | -0.52 | MXN 977 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
FibroGen | Mexico | Healthcare | Biotechnology & Medical Research | MXN 685.93M | -0.3x | -0 | MXN 7.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |